Literature DB >> 29507451

Observations on the launch of new drugs for hepatitis C.

Marianne Martinello1, Behzad Hajarizadeh2, Gregory J Dore3.   

Abstract

Keywords:  direct-acting antiviral drugs; hepatitis C

Year:  2018        PMID： 29507451      PMCID： PMC5828927          DOI： 10.18773/austprescr.2018.005

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  3 in total

Review 1.  Hepatitis C treatment as prevention: evidence, feasibility, and challenges.

Authors:  Behzad Hajarizadeh; Jason Grebely; Marianne Martinello; Gail V Matthews; Andrew R Lloyd; Gregory J Dore
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-11-10

2.  Uptake of direct-acting antiviral treatment for chronic hepatitis C in Australia.

Authors:  B Hajarizadeh; J Grebely; G V Matthews; M Martinello; G J Dore
Journal:  J Viral Hepat       Date:  2018-02-19       Impact factor: 3.728

Review 3.  Hepatitis C virus infection.

Authors:  Michael P Manns; Maria Buti; Ed Gane; Jean-Michel Pawlotsky; Homie Razavi; Norah Terrault; Zobair Younossi
Journal:  Nat Rev Dis Primers       Date:  2017-03-02       Impact factor: 52.329
  3 in total
  1 in total

1.  Hepatitis C cure as a 'gathering': Attending to the social and material relations of hepatitis C treatment.

Authors:  Adrian Farrugia; Renae Fomiatti; Suzanne Fraser; David Moore; Michael Edwards; Elizabeth Birbilis; Carla Treloar
Journal:  Sociol Health Illn       Date:  2022-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.